ARAY
Price
$2.19
Change
+$0.01 (+0.46%)
Updated
Apr 26, 6:59 PM EST
4 days until earnings call
RVTY
Price
$101.45
Change
-$0.67 (-0.66%)
Updated
Apr 26, 6:59 PM EST
2 days until earnings call
Ad is loading...

ARAY vs RVTY ᐉ Comparison: Which is Better to Invest?

Header iconARAY vs RVTY Comparison
Open Charts ARAY vs RVTYBanner chart's image
Accuray
Price$2.19
Change+$0.01 (+0.46%)
Volume$200.11K
CapitalizationN/A
Revvity
Price$101.45
Change-$0.67 (-0.66%)
Volume$235.62K
CapitalizationN/A
View a ticker or compare two or three
ARAY vs RVTY Comparison Chart

Loading...

ARAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RVTYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ARAY vs. RVTY commentary
Apr 27, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARAY is a Buy and RVTY is a Hold.

COMPARISON
Comparison
Apr 27, 2024
Stock price -- (ARAY: $2.19 vs. RVTY: $101.51)
Brand notoriety: ARAY and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ARAY: 75% vs. RVTY: 96%
Market capitalization -- ARAY: $244.95M vs. RVTY: $12.76B
ARAY [@Medical Specialties] is valued at $244.95M. RVTY’s [@Medical Specialties] market capitalization is $12.76B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARAY’s FA Score shows that 0 FA rating(s) are green whileRVTY’s FA Score has 1 green FA rating(s).

  • ARAY’s FA Score: 0 green, 5 red.
  • RVTY’s FA Score: 1 green, 4 red.
According to our system of comparison, RVTY is a better buy in the long-term than ARAY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARAY’s TA Score shows that 4 TA indicator(s) are bullish while RVTY’s TA Score has 1 bullish TA indicator(s).

  • ARAY’s TA Score: 4 bullish, 3 bearish.
  • RVTY’s TA Score: 1 bullish, 8 bearish.
According to our system of comparison, ARAY is a better buy in the short-term than RVTY.

Price Growth

ARAY (@Medical Specialties) experienced а +2.34% price change this week, while RVTY (@Medical Specialties) price change was +0.64% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.43%. For the same industry, the average monthly price growth was -5.27%, and the average quarterly price growth was +16.21%.

Reported Earning Dates

ARAY is expected to report earnings on Aug 15, 2024.

RVTY is expected to report earnings on Jul 30, 2024.

Industries' Descriptions

@Medical Specialties (+0.43% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for ARAY with price predictions.
OPEN
A.I.dvisor published
a Summary for RVTY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RVTY($12.8B) has a higher market cap than ARAY($245M). RVTY YTD gains are higher at: -7.074 vs. ARAY (-22.615). RVTY has higher annual earnings (EBITDA): 714M vs. ARAY (5.93M). RVTY has more cash in the bank: 1.6B vs. ARAY (72.8M). ARAY has less debt than RVTY: ARAY (202M) vs RVTY (4.07B). RVTY has higher revenues than ARAY: RVTY (2.75B) vs ARAY (447M).
ARAYRVTYARAY / RVTY
Capitalization245M12.8B2%
EBITDA5.93M714M1%
Gain YTD-22.615-7.074320%
P/E RatioN/A71.72-
Revenue447M2.75B16%
Total Cash72.8M1.6B5%
Total Debt202M4.07B5%
FUNDAMENTALS RATINGS
ARAY vs RVTY: Fundamental Ratings
ARAY
RVTY
OUTLOOK RATING
1..100
1671
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
77
Overvalued
PROFIT vs RISK RATING
1..100
10093
SMR RATING
1..100
9674
PRICE GROWTH RATING
1..100
8161
P/E GROWTH RATING
1..100
4910
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RVTY's Valuation (77) in the Medical Specialties industry is in the same range as ARAY (83). This means that RVTY’s stock grew similarly to ARAY’s over the last 12 months.

RVTY's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as ARAY (100). This means that RVTY’s stock grew similarly to ARAY’s over the last 12 months.

RVTY's SMR Rating (74) in the Medical Specialties industry is in the same range as ARAY (96). This means that RVTY’s stock grew similarly to ARAY’s over the last 12 months.

RVTY's Price Growth Rating (61) in the Medical Specialties industry is in the same range as ARAY (81). This means that RVTY’s stock grew similarly to ARAY’s over the last 12 months.

RVTY's P/E Growth Rating (10) in the Medical Specialties industry is somewhat better than the same rating for ARAY (49). This means that RVTY’s stock grew somewhat faster than ARAY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARAYRVTY
RSI
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
56%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
69%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 5 days ago
74%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 2 days ago
63%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
54%
View a ticker or compare two or three
Ad is loading...
ARAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RVTYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TIVFX17.760.25
+1.43%
American Beacon EAM Int Small Cap Cl
SCOBX38.820.43
+1.12%
DWS International Growth S
MEFNX12.040.04
+0.33%
MassMutual Mid Cap Growth R3
IRVAX29.83-0.06
-0.20%
Voya Russell Large Cap Value Idx Port A
BKPSX41.21-0.19
-0.46%
ProFunds Banks UltraSector Svc

ARAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ARAY has been loosely correlated with VREX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ARAY jumps, then VREX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARAY
1D Price
Change %
ARAY100%
+0.46%
VREX - ARAY
44%
Loosely correlated
-0.65%
VCYT - ARAY
42%
Loosely correlated
-0.87%
KIDS - ARAY
41%
Loosely correlated
+1.07%
TWST - ARAY
41%
Loosely correlated
+1.48%
CERS - ARAY
41%
Loosely correlated
+0.59%
More

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been loosely correlated with WAT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RVTY jumps, then WAT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
-0.57%
WAT - RVTY
61%
Loosely correlated
+0.96%
CNMD - RVTY
60%
Loosely correlated
+6.27%
SYK - RVTY
60%
Loosely correlated
-0.46%
MASI - RVTY
59%
Loosely correlated
+0.67%
NSTGQ - RVTY
57%
Loosely correlated
+1.75%
More